Confirmatory Study of FYU-981 for Hyperuricemia With or Without Gout (Phase II (IIb) Study)
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2017
At a glance
- Drugs FYU-981 (Primary)
- Indications Hyperuricaemia
- Focus Pharmacodynamics
- Sponsors Fuji Yakuhin
- 13 Feb 2017 Status changed from active, no longer recruiting to completed.
- 19 May 2015 Status changed from not yet recruiting to recruiting, according to to ClinicalTrials.gov record.
- 17 Apr 2015 New trial record